Karina Meijer

MD, PhD, professor
Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Groningen, Groningen, Netherlands

Presentation(s):

• PB0278 - Current practice regarding Bleeding Disorder of Unknown Cause (BDUC) in the Netherlands: a national survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0285 - Diagnosing and treating Bleeding Disorder of Unknown Cause: an illustrated review on current practice and future directions

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0261 - Investigating effectiveness and safety of extended dosing regimens of damoctocog alfa pegol in the real-world HEM-POWR study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0397 - Long-term anticoagulation management in patients with venous thromboembolism: evaluation of an outpatient clinic led by a nurse practitioner

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0280 - Patient perspective of the burden and severity of von Willebrand disease

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0426 - Preferences of thromboprophylaxis in the intensive care unit: an international survey

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 39.5 - Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin deficient patients: Data from the RBiN study

  Monday, June 24, 2024
  10:30 – 10:45 ICT

• PB0525 - Real-world Bleeding Rates on Emicizumab using Digital Treatment Diary data

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 52.3 - Randomized interventions aimed to improve oral anticoagulation outcomes, a systematic review and meta-analysis

  Tuesday, June 25, 2024
  10:00 – 10:15 ICT

• PB1446 - Direct oral anticoagulants for thromboprophylaxis in multiple myeloma – a systematic review and meta-analysis

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 73.4 - Personalized treatment by pharmacokinetic-guided dosing in von Willebrand disease; A prospective multicenter study, OPTI-CLOT/To WiN study

  Wednesday, June 26, 2024
  11:00 – 11:15 ICT